Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Zhongzhi Pharmaceutical Holdings Limited (HK:3737)
:3737
Holding HK:3737?
Track your performance easily
3737 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.82 - HK$1.46
Previous CloseN/A
Volume157.00K
Average Volume (3M)297.90K
Market Cap
HK$847.00M
Enterprise ValueHK$1.24B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)7.0
Beta0.24
Next Earnings
Mar 20, 2025EPS EstimateN/A
Last Dividend Ex-Date
May 24, 2024Dividend Yield9.09%
Share Statistics
EPS (TTM)0.14
Shares Outstanding863,600,000
10 Day Avg. Volume266,500
30 Day Avg. Volume297,900
Standard Deviation0.11
R-Squared0.06
Alpha0.00475
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Zhongzhi Pharmaceutical Holdings Limited News
PremiumCompany Announcements
Zhongzhi Pharmaceutical Issues Profit Warning for 2024
PremiumCompany Announcements
Zhongzhi Pharmaceutical Invests in Alzheimer’s Breakthrough
PremiumCompany Announcements
Zhongzhi Pharma to Gain Equity in Herb Pieces
PremiumCompany Announcements
Zhongzhi Pharma Announces Director Resignation
PremiumCompany Announcements
Zhongzhi Pharma Announces Board Structure
PremiumCompany Announcements
Zhongzhi Pharma Reports Declining ProfitsPremiumCompany Announcements
Zhongzhi Pharmaceutical Announces Upcoming Board Meeting
PremiumCompany Announcements
Zhongzhi Pharma Expects 40% Profit DropOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
<0.01%
Mutual Funds
― Other Institutional Investors
99.99% Public Companies and
Individual Investors
3737 FAQ
What was Zhongzhi Pharmaceutical Holdings Limited’s price range in the past 12 months?
Zhongzhi Pharmaceutical Holdings Limited lowest stock price was HK$0.82 and its highest was HK$1.46 in the past 12 months.
What is Zhongzhi Pharmaceutical Holdings Limited’s market cap?
Zhongzhi Pharmaceutical Holdings Limited’s market cap is HK$847.00M.
When is Zhongzhi Pharmaceutical Holdings Limited’s upcoming earnings report date?
Zhongzhi Pharmaceutical Holdings Limited’s upcoming earnings report date is Mar 20, 2025 which is in 54 days.
How were Zhongzhi Pharmaceutical Holdings Limited’s earnings last quarter?
Zhongzhi Pharmaceutical Holdings Limited released its earnings results on Aug 23, 2024. The company reported HK$0.107 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.107.
Is Zhongzhi Pharmaceutical Holdings Limited overvalued?
According to Wall Street analysts Zhongzhi Pharmaceutical Holdings Limited’s price is currently Overvalued.
Does Zhongzhi Pharmaceutical Holdings Limited pay dividends?
Zhongzhi Pharmaceutical Holdings Limited pays a Semiannually dividend of HK$0.029 which represents an annual dividend yield of 9.09%. See more information on Zhongzhi Pharmaceutical Holdings Limited dividends here
What is Zhongzhi Pharmaceutical Holdings Limited’s EPS estimate?
Zhongzhi Pharmaceutical Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zhongzhi Pharmaceutical Holdings Limited have?
Zhongzhi Pharmaceutical Holdings Limited has 863,600,000 shares outstanding.
What happened to Zhongzhi Pharmaceutical Holdings Limited’s price movement after its last earnings report?
Zhongzhi Pharmaceutical Holdings Limited reported an EPS of HK$0.107 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.222%.
Which hedge fund is a major shareholder of Zhongzhi Pharmaceutical Holdings Limited?
Currently, no hedge funds are holding shares in HK:3737
---
Zhongzhi Pharmaceutical Holdings Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.31%
12-Months-Change
Fundamentals
Return on Equity
10.29%
Trailing 12-Months
Asset Growth
9.47%
Trailing 12-Months
Technical Analysis
Ping An Insurance Company of China
―
Sino Biopharmaceutical
―
Guangzhou Baiyunshan Pharmaceutical Holdings Company
―
Sinopharm Group Co
―
3SBio
―
---